Patents by Inventor William Mark Erwin

William Mark Erwin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
    Publication number: 20230121154
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Application
    Filed: September 6, 2022
    Publication date: April 20, 2023
    Inventors: William Mark ERWIN, Bjorn C. J. EEK
  • Compositions and methods for degenerative disc regeneration
    Patent number: 11491180
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: November 8, 2022
    Assignees: UNIVERSITY HEALTH NETWORK, NOTOGEN. INC.
    Inventors: William Mark Erwin, Bjorn C. J. Eek
  • Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
    Patent number: 11471480
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Grant
    Filed: June 25, 2021
    Date of Patent: October 18, 2022
    Assignees: UNIVERSITY HEALTH NETWORK, NOTOGEN, INC.
    Inventors: William Mark Erwin, Bjorn C. J. Eek
  • COMPOSITIONS AND METHODS COMPRISING GROWTH FACTORS, CHONDROITIN AND GLUCOSAMINE FOR DEGENERATIVE DISC REGENERATION
    Publication number: 20210353664
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Application
    Filed: June 25, 2021
    Publication date: November 18, 2021
    Inventor: William Mark ERWIN
  • COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
    Publication number: 20210315922
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 14, 2021
    Inventor: William Mark ERWIN
  • Compositions and methods for degenerative disc regeneration
    Patent number: 11141427
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Grant
    Filed: July 29, 2019
    Date of Patent: October 12, 2021
    Assignee: UNIVERSITY HEALTH NETWORK
    Inventor: William Mark Erwin
  • Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
    Patent number: 11141426
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: October 12, 2021
    Assignee: UNIVERSITY HEALTH NETWORK
    Inventor: William Mark Erwin
  • Compositions and methods for degenerative disc regeneration
    Publication number: 20190350968
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Application
    Filed: July 29, 2019
    Publication date: November 21, 2019
    Inventor: William Mark Erwin
  • COMPOSITIONS AND METHODS COMPRISING GROWTH FACTORS, CHONDROITIN AND GLUCOSAMINE FOR DEGENERATIVE DISC REGENERATION
    Publication number: 20180169137
    Abstract: There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.
    Type: Application
    Filed: November 4, 2016
    Publication date: June 21, 2018
    Applicant: UNIVERSITY HEALTH NETWORK
    Inventor: William Mark ERWIN
  • METHODS AND USES OF HYPOXIC COMPARTMENT CELLS
    Publication number: 20120045419
    Abstract: The disclosure relates to methods of maintaining and/or expanding an in vitro population of hypoxia compartment cells comprising culturing said population of cells optionally in an oxygen controlled environment, wherein the population of hypoxia compartment cells is exposed to an oxygen concentration of between about 1.5% and about 10%, preferably between about 2% and about 5%, and uses of cells expanded according to these methods.
    Type: Application
    Filed: February 5, 2010
    Publication date: February 23, 2012
    Applicant: UNIVERSITY HEALTH NETWORK
    Inventors: William Mark Erwin, Michael George Fehlings, Robert Davies Inman